相关实验视频
Updated: Sep 23, 2026

08:51
Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-PCR)
Published on: November 4, 2016
在从无症状载体中分离的持久性A组链球菌菌株中,内部化相关基因prtF1的流行率
R Neeman1, N Keller, A Barzilai
1Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Israel.
Lancet (London, England)
|January 1, 1999
概括
在抗生素治疗后,A组链球菌 (GAS) 在喉的持续性与纤维素结合蛋白 (F1) 基因有关. 这表明细胞内细菌储存体有助于治疗失败的pharyngotonsillitis.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 分子生物学分子生物学
背景情况:
- 抗生素治疗未能在高达30%的喉突炎患者中根除A组链球菌 (GAS).
- 气体菌株可以进入呼吸道上皮细胞,形成细胞内存储库,无法接触到像青素这样的抗生素.
- 纤维素结合蛋白 (F1和SfbI) 对于这种细胞内侵入至关重要.
研究的目的:
- 调查纤维素结合蛋白 (F1) 基因与抗生素治疗后喉中GAS持久性之间的联系.
- 为了确定细胞内气体储存是否导致治疗失败.
主要方法:
- 在67名喉炎患者中研究了prtF1-含有GAS菌株的频率.
- 分析了来自13名持久携带患者的分离物,使用血清学测试和多态DNA放大来区分持久和重新殖民菌株.
主要成果:
- 92%的无症状携带患者有prtF1含有菌株,而成功根除的患者只有30% (p=0.0001).
- 90%的持久性GAS菌株携带prtF1基因 (p=0.0009).
- 三名患者被重新定居在不同的GAS菌株中;九名患者持久性菌株携带prtF1.1.
结论:
- 蛋白F1介导的细胞进入与GAS载体状态的发展有关.
- 细胞内气体储存可能导致喉囊炎的治疗失败.
相关概念视频
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

